Fair Value Calculator Fair Value Calculator
EN DE

Quantum-Si incorporated, a life sciences company, (QSI) Fair Value & Analysis

Healthcare · US · Market cap $218M

QS Quantum-Si incorporated, a life sciences company, logo Quantum-Si incorporated, a life sciences company, QSI · US
Price$0.8360
Fair Value$0.6460
Upside-22.7%
Quality13/100
Watch Quantum-Si incorporated, a life sciences company, for free, get notified when fair value or trend changes. Watch for free
Evidence: Low Range $0.4250 – $0.8075 📤 Share as image

Fair value as of: Jul 18, 2026

From 1 valuation models · updated 5 days ago

Share price −16.3% over the past month.

Price vs Fair Value (12 months)

$2.63 $0.7110 Fair Value $0.6460 Jul 2025 Jul 2026

12‑month range $0.7110 – $2.63 · fair‑value band $0.4250 – $0.8075 · the $0.8360 price screens above the $0.6460 fair value. As of Jul 18, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Quantum-Si incorporated, a life sciences company, (QSI) currently trades at $0.8360, while our model-based Fair Value estimate is $0.6460, implying the stock looks roughly 22.7% overvalued today. We read business quality at 13/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at $1.9M. Revenue declined 69.4% year over year. It earns a return on equity of -46.4%. The balance sheet holds a net cash position of $17.5M. Fundamentals as of Jul 18, 2026

Our scenario range runs from $0.4250 (bear case) to $0.8075 (bull case); at $0.8360, the current price sits above that range. The share trades about 73% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -29% fair-value upside, at -23%, QSI screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $1.9M
Revenue growth (YoY) -69.4%
Return on equity -46.4%
Free cash flow −$97.2M FY2025
Operating margin -9,323%
EPS (TTM) $-0.5000
More key figures
Net cash $17.5M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.

About the company

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Quantum-Si incorporated, a life sciences company, reported revenue of $2.4M in FY2025 versus $0 in FY2021. Reported net income was −$101M in FY2025.

Revenue
FY21 $0
FY22 $459K
FY23 $1.1M
FY24 $3.1M
FY25 $2.4M
Net income
FY21 −$95.0M
FY22 −$132M
FY23 −$96.0M
FY24 −$101M
FY25 −$101M

Is QSI fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Quantum-Si incorporated, a life sciences company, Fair Value". https://www.fairvalue-calculator.com/stock/QSI

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $90.53 $79.67 -12%
Stryker Corporation SYK $310.00 $186.28 -40%
Medtronic plc MDTC34 R$211.05 R$29.52 -86%
Boston Scientific Corporation B1SX34 R$247.01 R$234.82 -5%
Edwards Lifesciences Corporation EWL €74.64 €31.98 -57%
Siemens Healthineers AG SEMHF $39.95 $44.36 +11%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥141.85 ¥147.63 +4%
STERIS plc S1TE34 R$52.14 R$8.02 -85%
Zimmer Biomet Holdings Z1BH34 R$119.88 R$85.65 -29%
Shanghai United Imaging Healthcare Co 688271 ¥104.19 ¥45.36 -56%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Quantum-Si incorporated, a life sciences company, (QSI) undervalued?
As of Jul 18, 2026, our model estimates a fair value of $0.6460 versus a price of $0.8360, about −23% (overvalued). Model-based estimate, not financial advice.
What is the fair value of QSI?
Our model-based fair value for Quantum-Si incorporated, a life sciences company, is $0.6460 (as of Jul 18, 2026), built from audited fundamentals. The current price is $0.8360.
What is the quality score of QSI?
Quantum-Si incorporated, a life sciences company, has a Quality Score of 13/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Quantum-Si incorporated, a life sciences company, (QSI)?
Quantum-Si incorporated, a life sciences company, reported trailing-twelve-month revenue of about $1.9M (latest available figure, as of Jul 18, 2026).
What is the net profit margin of QSI?
The net profit margin of Quantum-Si incorporated, a life sciences company, is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Quantum-Si incorporated, a life sciences company, analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.